Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.001
-0.069 (-3.33%)
At close: Apr 2, 2026, 4:00 PM EDT
2.010
+0.009 (0.45%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $78.68 million as of April 2, 2026. Its market cap has decreased by -49.54% in one year.
Market Cap
78.68M
Enterprise Value
-14.76M
1-Year Change
-49.54%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $78.68M, a decrease of -83.88%. That is a compound annual growth rate of -32.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 78.68M | -30.90% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 93.42M |
| MaxCyte | 80.10M |
| QT Imaging Holdings | 78.88M |
| Outset Medical | 73.43M |
| LENSAR | 73.30M |
| InspireMD | 72.07M |
| Picard Medical | 71.49M |
| Baird Medical Investment Holdings | 71.25M |